Defining potency of CAR+ T cells: Fast and furious or slow and steady
Genetically engineered T cells that express chimeric antigen receptors (CAR+) are heterogeneous and thus, understanding the immunotherapeutic efficacy remains a challenge in adoptive cell therapy.We developed a high-throughput single-cell click here methodology, Timelapse Imaging Microscopy In Nanowell Grids (TIMING) to monitor interactions between